Teachers Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$1.47M Buy
29,018
+2,099
+8% +$93.4K ﹤0.01% 2127
2018
Q4
$1.08M Buy
26,919
+267
+1% +$13.8K ﹤0.01% 2153
2018
Q3
$1.85M Buy
26,652
+7,751
+41% +$588K ﹤0.01% 2008
2018
Q2
$1.43M Buy
18,901
+3,505
+23% +$221K ﹤0.01% 2139
2018
Q1
$811K Buy
15,396
+106
+0.7% +$6.16K ﹤0.01% 2315
2017
Q4
$817K Buy
15,290
+244
+2% +$13.6K ﹤0.01% 2340
2017
Q3
$897K Sell
15,046
-293
-2% -$17.7K ﹤0.01% 2294
2017
Q2
$1.21M Sell
15,339
-578
-4% -$47.3K ﹤0.01% 2121
2017
Q1
$1.32M Buy
15,917
+380
+2% +$28.3K ﹤0.01% 2020
2016
Q4
$1.23M Buy
15,537
+752
+5% +$54.6K ﹤0.01% 2058
2016
Q3
$1.03M Sell
14,785
-194
-1% -$10.7K ﹤0.01% 2053
2016
Q2
$581K Buy
14,979
+27
+0.2% +$1.12K ﹤0.01% 2335
2016
Q1
$606K Buy
14,952
+2,143
+17% +$136K ﹤0.01% 2236
2015
Q4
$1.14M Hold
12,809
﹤0.01% 1950
2015
Q3
$948K Buy
12,809
+294
+2% +$24.5K ﹤0.01% 2025
2015
Q2
$1.01M Buy
+12,515
New +$815K ﹤0.01% 2114
2014
Q2
Sell
-3,400
Closed -$43K 3185
2014
Q1
$43K Buy
+3,400
New +$46.2K ﹤0.01% 3082

Other funds holding EGRX

Teachers Advisors's EGRX Position: Q1 2019 in Review

Teachers Advisors increased its Eagle Pharmaceuticals, Inc. (EGRX) stake by 7.8% in Q1 2019, buying an estimated $93.4K and bringing the position to 29,018 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #2127.

Teachers Advisors first reported a position in EGRX in Q1 2014 and has held it in 17 quarters since. The position peaked at $1.85M in Q3 2018. 182 funds tracked by Wall St. Rank hold EGRX as of Q1 2019.

  • Teachers Advisors held 29,018 shares of Eagle Pharmaceuticals, Inc. worth $1.47M as of Q1 2019.
  • Teachers Advisors bought 2,099 Eagle Pharmaceuticals, Inc. shares in Q1 2019, an estimated $93.4K.
  • Eagle Pharmaceuticals, Inc. made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2127 holding.
  • Teachers Advisors first reported a position in Eagle Pharmaceuticals, Inc. in Q1 2014 and has held it in 17 quarters since.
  • Teachers Advisors's Eagle Pharmaceuticals, Inc. position peaked at $1.85M in Q3 2018.
  • 182 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.